Invitrogen™ Human HAX1 alpha Synthetic Peptide

Ref.: BL-RE-175597Manufacturer ref.: PEP-0769 50 μg
€149.00 excl. VAT

Hax1a Synthetic Peptide, PEP-0769, from Invitrogen.

Gene ID (Enter)
10456
Species
Human
Purification method
Purified
Accession number
O00165
Common name
Human HAX1 alpha
Brand
Invitrogen

Hax1a Synthetic Peptide, PEP-0769, from Invitrogen.

Hax1a Synthetic Peptide, PEP-0769, from Invitrogen.

The HS-1 associated protein X-1 (Hax1) was initially identified in a yeast two-hybrid assay on the basis of its ability to bind to the hemapoietic cell-specific protein 1 (HS-1). Hax1 possesses anti-apoptotic activity and is structurally related to Bcl-2 family members, including the presence of BH1- and BH2-like domains. It has recently been shown to interact with HIV viral protein R (Vpr), a protein required for viral pathogenesis of HIV and linked to T-cell apoptosis through activation of caspases 3 and 9. Other studies indicate that Hax1-mediated processing of HtrA2 (also known as Omi) by the mitochondrial protease PARL allows survival of lymphocytes and neurons when cytokines are limiting.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15318990
Specifications
Gene ID (Enter)10456
SpeciesHuman
Purification methodPurified
Accession numberO00165
Common nameHuman HAX1 alpha
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)HAX1
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0769
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.